Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding

Exagen (XGN) remains unprofitable, but the company has managed to cut its annual losses by 4.7% over the last five years. While forecasts call for continued red ink over the next three years, revenue ...

NYC Real Estate Outlook as Mayoral Race Underway

Frances Katzen, Broker at Douglas Elliman and Founder of The Katzen Team, says this year's New York City mayoral election is ...